InvestorsHub Logo
Followers 14
Posts 734
Boards Moderated 0
Alias Born 12/09/2013

Re: biotech_researcher post# 1077

Thursday, 08/20/2015 12:29:45 PM

Thursday, August 20, 2015 12:29:45 PM

Post# of 3205
$GILD $ABBV $ENTA Post Launch:

Things could change.
I see that the twitter chart shows Viekira TRX at 475

per this post, the END of July was TRX 1069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116123862

I will note that the highway bill passed in July will provide additional VA funding for both Abbvie and Gilead, but that the Viekira might get about 25% of the 500 million. (we will see).

Viekira was just also approved for G-4, so there should be higher revenues due to that (and a higher royalty rate)
FDA approval 7/24/2015

And it seems that Abbvie is doing better in EU than was earlier expected, so mere US numbers do not paint the complete picture. At the Abbvie ER I think they listed about 20% EU market share.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News